Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Transpl Int. 2013 Jun 11;26(8):788–794. doi: 10.1111/tri.12123

Table 1.

Baseline characteristics of patients with alcoholic cirrhosis receiving liver transplantation: comparison over time and based on the presence or absence of concomitant hepatitis C virus (HCV) and/or hepatocellular carcinoma (HCC).

Year groups
Concomitant HCV and/or HCC
All (261) 1988–2000 (77) 2001–2006 (86) 2007–2011 (98) P Alcohol (129) With HCV (64) With HCC (32) With HCV+HCC (36) P
Age 53 ± 8 50 ± 8 53 ± 8 55 ± 7 0.066 53 ± 8 50 ± 7 60 ± 6 55 ± 5 <0.0001
% Males 206 (79) 56 (73) 74 (86) 76 (78) 0.1 91 (71) 54 (84) 28 (88) 33 (92) 0.009
Alcohol g/d 83 ± 57 89 ± 65 87 ± 54 74 ± 52 0.85 88 ± 61 83 ± 55 84 ± 63 63 ± 38 0.1
Dialysis (%) 28 (11) 2 (3) 14 (17) 12 (13) 0.015 20 (16) 6 (9) 2 (7) 0 (0) 0.044
MELD 19 ± 8 18 ± 7 19 ± 8 19 ± 8 0.045 21 ± 8 21 ± 9 14 ± 6 13 ± 4 <0.0001
Albumin 3.3 ± 0.57 3.1 ± 0.56 3.3 ± 0.53 3.4 ± 0.58 0.39 3.2 ± 0.6 3.2 ± 0.6 3.3 ± 0.5 3.4 ± 0.5 0.47
Sodium 136 ± 5 136 ± 5 136 ± 5 136 ± 4 0.78 136 ± 5 136 ± 5 136 ± 5 137 ± 3 0.51

MELD, model end-stage liver disease.